id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-342405-nsj9dh48	Chakraborty, Chiranjib	India’s cost-effective COVID-19 vaccine development initiatives	2020-10-20		.txt	text/plain	522	38	56	title: India's cost-effective COVID-19 vaccine development initiatives In addition, millions of people who live across over 30 world's poorest countries will also expect the affordable low-cost vaccine. It's currently collaborating with Codagenix to develop a vaccine, including live-attenuated vaccine against COVID-19. 6 Besides, it has a partnership with Codagenix, a New York based firm specialized on vaccines and the Oxford University to produce the COVID-19 vaccine. 10 What's unique about India is that it has the expertise for low-cost per-unit vaccine production of vaccines. Due to the low cost vaccine making history, new products against COVID-19 will be of great use in over 30 low-income countries worldwide benefiting millions of people who cannot afford expensive vaccines. Few months ago, the WHO has praised India's vaccine production capacity in a meeting of COVID-19. It's time for the developing world to collaborate with India to produce and distribute the cost-effective COVID-19 vaccine as soon as possible.	./cache/cord-342405-nsj9dh48.txt	./txt/cord-342405-nsj9dh48.txt